drugset / Trial / NCT00366171
Open Label Extension Study of Bifeprunox
Non-randomizedSingle-groupOpen-labelTreatment
Summary
A one year extension study using flexible doses, 20 or 30 mg daily, of open-label bifeprunox.
Timeline
- Start
- 2006-11
- Primary completion
- —
- Completion
- 2007-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bifeprunox | Small molecule | 20 mg | — |
| Subject | Bifeprunox | Small molecule | 30 mg | — |